BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
McKinsey
Queensland Health
Dow
Medtronic
McKesson
Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Healthtrust

Generated: January 23, 2018

DrugPatentWatch Database Preview

Velaglucerase alfa - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for velaglucerase alfa and what is the scope of velaglucerase alfa freedom to operate?

Velaglucerase alfa
is the generic ingredient in one branded drug marketed by Shire Human Genetic and is included in one NDA. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.
Summary for velaglucerase alfa
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Clinical Trials: 5
Drug Prices:see low prices
DailyMed Link:velaglucerase alfa at DailyMed
Pharmacology for velaglucerase alfa

US Patents and Regulatory Information for velaglucerase alfa

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shire Human Genetic VPRIV velaglucerase alfa POWDER;IV (INFUSION) 022575-002 Feb 26, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Shire Human Genetic VPRIV velaglucerase alfa INJECTABLE;IV (INFUSION) 022575-001 Feb 26, 2010 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Federal Trade Commission
Novartis
Healthtrust
Merck
UBS
Teva
Colorcon
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot